# Find telehealth peptide providers in Tampa, Florida

PeptideClinic lists 1 telehealth peptide providers with an address in Tampa, Florida.

1 peptide provider. Also on the [web page](https://peptideclinic.fyi/florida/tampa/category/telehealth-peptide-providers).

## Peptide providers

1. [Defy Medical](https://peptideclinic.fyi/florida/tampa/defy-medical.md), Peptide therapy providers, 4809 N Armenia Ave Suite 220, Tampa: Telemedicine clinic led by a physician medical director; its website lists peptide therapy among its healthcare services, with an in-person clinic in Tampa.

## Other categories in Tampa

- [Peptide therapy providers](https://peptideclinic.fyi/florida/tampa/category/peptide-therapy-providers.md): 1 peptide provider

## Telehealth peptide providers in other cities

- [Ann Arbor](https://peptideclinic.fyi/michigan/ann-arbor/category/telehealth-peptide-providers.md): 1 peptide provider
- [Bloomfield Hills](https://peptideclinic.fyi/michigan/bloomfield-hills/category/telehealth-peptide-providers.md): 1 peptide provider
- [Tarzana](https://peptideclinic.fyi/california/tarzana/category/telehealth-peptide-providers.md): 1 peptide provider
- [Tempe](https://peptideclinic.fyi/arizona/tempe/category/telehealth-peptide-providers.md): 1 peptide provider

> **Not medical advice.** Regulatory status, checked 2026-10-20: FDA rules on the bulk substances a compounding pharmacy may use are in flux. A February 2026 HHS announcement moved about 14 peptides back toward the FDA Category 1 list, and sources disagree on the final status — check the FDA bulk-substances page (https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding) before you act. PeptideClinic is a directory, not a clinic or a pharmacy: a listing is a record, never an endorsement. It gives no dosing, no medical advice and no outcome claims, and it never lists research-chemical sellers. Confirm a provider's licence on the named state board, the FDA 503B register or the NPI registry before you book. In an emergency call 911.
